During the past decade, Suburban Hematology Oncology Associates - Snellville conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 3 clinical trials were completed, i.e. on average, 12% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suburban Hematology Oncology Associates - Snellville" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suburban Hematology Oncology Associates - Snellville" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Suburban Hematology Oncology Associates - Snellville" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (4 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Suburban Hematology Oncology Associates - Snellville" in a lesser frequency.

Most popular intervention types in "Suburban Hematology Oncology Associates - Snellville" are "Drug" (21 trials), "Other" (15 trials), "Biological" (12 trials), "Procedure" (9 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Computed Tomography" (7 trials), "Biospecimen Collection" (6 trials), "Pembrolizumab" (6 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Suburban Hematology Oncology Associates - Snellville" are 23 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Suburban Hematology Oncology Associates - Snellville". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Suburban Hematology Oncology Associates - Snellville, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Suburban Hematology Oncology Associates - Snellville, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".